- Home
- OBE vs OFIX Comparison
OBE vs OFIX Comparison
Compare OBE & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OBE | OFIX |
|---|---|---|
| Founded | 1979 | 1987 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 526.9M | 473.3M |
| IPO Year | 2005 | 1998 |
Fundamental Metrics
Financial Performance| Metric | OBE | OFIX |
|---|---|---|
| Price | $9.52 | $12.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $10.00 | ★ $17.25 |
| AVG Volume (30 Days) | ★ 907.2K | 231.3K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | N/A | $6.10 |
| Revenue Next Year | $20.21 | $6.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $3.88 | $10.25 |
| 52 Week High | $9.81 | $16.99 |
Technical Indicators
Market Signals| Indicator | OBE | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 59.73 | 60.70 |
| Support Level | $5.57 | $12.33 |
| Resistance Level | $9.81 | $16.38 |
| Average True Range (ATR) | 0.40 | 0.41 |
| MACD | -0.02 | 0.19 |
| Stochastic Oscillator | 76.98 | 85.48 |
Price Performance
Historical ComparisonAbout OBE Obsidian Energy Ltd.
Obsidian Energy Ltd is an intermediate-sized oil and gas producer with strategic assets in Alberta. It operates in a single reporting segment that is exploration, development, and holding an interest in oil and natural gas properties and related production infrastructure in the Western Canada Sedimentary Basin. The company generates the majority of the revenue from the Sale of Oil.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.